These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 3102252

  • 21. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice.
    Pfannes SD, Müller B, Körner S, Bessler WG, Hoffmann P.
    J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Vitamin C and immunity: influence of ascorbate on prostaglandin E2 synthesis and implications for natural killer cell activity.
    Siegel BV, Morton JI.
    Int J Vitam Nutr Res; 1984 Apr; 54(4):339-42. PubMed ID: 6597182
    [Abstract] [Full Text] [Related]

  • 24. Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved.
    Józefowski S, Bobek M, Marcinkiewicz J.
    Int Immunopharmacol; 2003 Jun; 3(6):865-78. PubMed ID: 12781703
    [Abstract] [Full Text] [Related]

  • 25. Antibody-dependent cellular cytotoxicity against tumor cells. I. Cultivated bone marrow-derived macrophages kill tumor targets.
    Lohmann-Matthes ML, Domzig W, Taskov H.
    Eur J Immunol; 1979 Apr; 9(4):261-6. PubMed ID: 467489
    [Abstract] [Full Text] [Related]

  • 26. Restoration of prostaglandin E2-producing splenic macrophages in 89Sr-treated mice with bone marrow from Corynebacterium parvum primed donors.
    Shibata Y.
    Reg Immunol; 1989 Apr; 2(3):169-75. PubMed ID: 2641504
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
    Hamann U, Krammer PH.
    Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924
    [Abstract] [Full Text] [Related]

  • 30. Dendritic cells issued in vitro from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells.
    Harizi H, Juzan M, Grosset C, Rashedi M, Gualde N.
    Cell Immunol; 2001 Apr 10; 209(1):19-28. PubMed ID: 11414733
    [Abstract] [Full Text] [Related]

  • 31. Trace levels of bacterial lipopolysaccharide prevent interferon-gamma or tumor necrosis factor-alpha from enhancing mouse peritoneal macrophage respiratory burst capacity.
    Ding AH, Nathan CF.
    J Immunol; 1987 Sep 15; 139(6):1971-7. PubMed ID: 3040860
    [Abstract] [Full Text] [Related]

  • 32. [Role of nitric oxide produced by activated macrophages in their cytocidal activity against glial tumor cells].
    Akiyama Y, Yamasaki T, Fukuda M, Moritake K.
    No To Shinkei; 1995 Apr 15; 47(4):349-55. PubMed ID: 7772402
    [Abstract] [Full Text] [Related]

  • 33. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.
    Zlotnik A, Fischer M, Roehm N, Zipori D.
    J Immunol; 1987 Jun 15; 138(12):4275-9. PubMed ID: 3495588
    [Abstract] [Full Text] [Related]

  • 34. Studies on the activation of mouse bone marrow-derived macrophages by the macrophage cytotoxicity factor (MCF).
    Meerpohl HG, Lohmann-Matthes ML, Fischer H.
    Eur J Immunol; 1976 Mar 15; 6(3):213-7. PubMed ID: 1086777
    [Abstract] [Full Text] [Related]

  • 35. Requirement for protein synthesis for induction of macrophage tumoricidal activity by IFN-alpha and IFN-beta but not by IFN-gamma.
    Blasi E, Herberman RB, Varesio L.
    J Immunol; 1984 Jun 15; 132(6):3226-8. PubMed ID: 6725951
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.
    Chen L, Suzuki Y, Wheelock EF.
    J Immunol; 1987 Dec 15; 139(12):4096-101. PubMed ID: 3121728
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.